24/7 Market News Snapshot 26 Jul 2024 – ProMIS Neurosciences Inc. Common Shares (ON) (NASDAQ: PMN)

July 26, 2024 7:44

Press Release

DENVER, Colo., 26 July, 2024 (247marketnews.com) – (Nasdaq:PMN) are discussed in this article.
ProMIS Neurosciences Inc. (PMN) has been attracting significant attention in the financial markets, experiencing a notable surge in its stock price, with pre-market trading indicating a substantial increase of 98.94% from the previous session. The stock, currently priced at $3.572, reflects heightened investor interest, supported by a robust trading volume of 1.6M shares. Technical analysis suggests a favorable outlook for continued growth, positioning ProMIS Neurosciences Inc. as a viable candidate for potential investment opportunities.

Furthermore, ProMIS Neurosciences Inc. has unveiled groundbreaking findings from its latest study on the PMN310 antibody, targeting Alzheimer’s disease treatment. The topline results demonstrate promising safety profiles and exceptional tolerability levels across escalating dose levels in healthy volunteers. Notably, the study revealed dose-dependent concentrations of PMN310 antibody in Cerebrospinal fluid (CSF), indicating a strong potential for effective target engagement in Alzheimer’s patients.

These significant advancements underscore the company’s commitment to pioneering innovative solutions in the realm of neurosciences. The impressive outcomes from the PMN310 antibody study signify a pivotal development in the quest to address Alzheimer’s disease and offer renewed hope to individuals grappling with neurodegenerative disorders.

ProMIS Neurosciences Inc.’s dedication to cutting-edge research and transformative progress in neuroscientific pursuits positions the company as a frontrunner in the industry. The disclosed results herald a new era of potential treatment modalities for Alzheimer’s disease, marking a substantial leap forward in the relentless battle against this widespread affliction.

For further insights into ProMIS Neurosciences Inc.’s revolutionary research endeavors and the implications of their latest findings, interested parties are encouraged to visit the official company website for comprehensive information.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 Market News, Inc Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.